Peptides are surging in popularity as wellness boosters, touted for muscle growth and anti-aging—but science says little to back up the hype. The FDA is now weighing whether to allow wider access, amid fierce debate. Health Secretary Robert F. Kennedy Jr. backs loosening restrictions, while career scientists and experts warn of risks with little evidence. Influencers and users push for approval, but some advisors on the review panel have ties to the industry, prompting the FDA to add more unbiased voices. Seven peptides are under review, with staff recommending against compounding them. The final decision will hinge on votes, public input, and possibly a temporary compromise that could open the door to broader access—just as Kennedy wants.
Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn.
Advertise on DNN: advertise@thednn.ai
This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai.
Podden och tillhörande omslagsbild på den här sidan tillhör
The Daily News Now!. Innehållet i podden är skapat av The Daily News Now! och inte av,
eller tillsammans med, Poddtoppen.
